IGFBP2 Is a Candidate Biomarker for Ink4a-Arf Status and a Therapeutic Target for High-Grade Gliomas

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0900807106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Ink4a/Arf Expression Is a Biomarker of Aging

Journal of Clinical Investigation
Medicine
2004English

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma

Haematologica
Hematology
2018English

TRPM2: A Candidate Therapeutic Target for Treating Neurological Diseases

Acta Pharmacologica Sinica
MedicinePharmacology
2018English

The Ink4a/Arf Locus Is a Barrier to Direct Neuronal Transdifferentiation

Journal of Neuroscience
Neuroscience
2014English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Surgical Ventricular Entry Is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas

Scientific Reports
Multidisciplinary
2015English

PROX1 Is a Predictor of Survival for Gliomas WHO Grade II

British Journal of Cancer
Cancer ResearchOncology
2011English

IGFBP2 Is a Biomarker for Predicting Longitudinal Deterioration in Renal Function in Type 2 Diabetes

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy